Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients
JAMA · 2023
DOI: 10.1001/jama.2023.14445 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JAMA, 2023. Verfasst von Jingcheng Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Cerebral Hemorrhage, Erythrocyte Transfusion, Communicable Diseases. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Alzheimer's Society, European Research Council.
Abstract (Originalsprache)
Importance Recent reports have suggested that cerebral amyloid angiopathy, a common cause of multiple spontaneous intracerebral hemorrhages (ICHs), may be transmissible through parenteral injection of contaminated cadaveric pituitary hormone in humans.
Objective
To determine whether spontaneous ICH in blood donors after blood donation is associated with development of spontaneous ICH in transfusion recipients. Design, Setting, and Participants Exploratory retrospective cohort study using nationwide blood bank and health register data from Sweden (main cohort) and Denmark (validation cohort) and including all 1 089 370 patients aged 5 to 80 years recorded to have received a red blood cell transfusion from January 1, 1970 (Sweden), or January 1, 1980 (Denmark), until December 31, 2017. Exposures Receipt of red blood cell transfusions from blood donors who subsequently developed (1) a single spontaneous ICH, (2) multiple spontaneous ICHs, or (3) no spontaneous ICH. Main Outcomes and Measures Spontaneous ICH in transfusion recipients; ischemic stroke was a negative control outcome.
Results
A total of 759 858 patients from Sweden (median age, 65 [IQR, 48-73] years; 59% female) and 329 512 from Denmark (median age, 64 [IQR, 50-73] years; 58% female) were included, with a median follow-up of 5.8 (IQR, 1.4-12.5) years and 6.1 (IQR, 1.5-11.6) years, respectively. Patients who underwent transfusion with red blood cell units from donors who developed multiple spontaneous ICHs had a significantly higher risk of a single spontaneous ICH themselves, compared with patients receiving transfusions from donors who did not develop spontaneous ICH, in both the Swedish cohort (unadjusted incidence rate [IR], 3.16 vs 1.12 per 1000 person-years; adjusted hazard ratio [HR], 2.73; 95% CI, 1.72-4.35; P < .001) and the Danish cohort (unadjusted IR, 2.82 vs 1.09 per 1000 person-years; adjusted HR, 2.32; 95% CI, 1.04-5.19; P = .04). No significant difference was found for patients receiving transfusions from donors who developed a single spontaneous ICH in the Swedish cohort (unadjusted IR, 1.35 vs 1.12 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.84-1.36; P = .62) nor the Danish cohort (unadjusted IR, 1.36 vs 1.09 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.70-1.60; P = .73), nor for ischemic stroke as a negative control outcome. Conclusions and Relevance In an exploratory analysis of patients who received red blood cell transfusions, patients who underwent transfusion with red blood cells from donors who later developed multiple spontaneous ICHs were at significantly increased risk of spontaneous ICH themselves. This may suggest a transfusion-transmissible agent associated with some types of spontaneous ICH, although the findings may be susceptible to selection bias and residual confounding, and further research is needed to investigate if transfusion transmission of cerebral amyloid angiopathy might explain this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
- Danish Cancer Society Research Center, Copenhagen, Denmark.
- VIB Center for Brain and Disease Research, Leuven, Belgium.
- Hematology Department, Karolinska University Hospital, Stockholdm, Sweden.
- Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Förderung
- Alzheimer's Society
- European Research Council
Zitieren
APA
Zhao, J., Rostgaard, K., Lauwers, E., Dahlén, T., Ostrowski, S. R., Erikstrup, C., Pedersen, O. B., de Strooper, B., Lemmens, R., Hjalgrim, H., & Edgren, G. (2023). Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients. JAMA. https://doi.org/10.1001/jama.2023.14445
Vancouver
Zhao J, Rostgaard K, Lauwers E, Dahlén T, Ostrowski SR, Erikstrup C, et al. Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients. JAMA. 2023. doi:10.1001/jama.2023.14445
BibTeX
@article{Zhao2023,
author = {Zhao, Jingcheng and Rostgaard, Klaus and Lauwers, Elsa and Dahlén, Torsten and Ostrowski, Sisse Rye and Erikstrup, Christian and Pedersen, Ole Birger and de Strooper, Bart and Lemmens, Robin and Hjalgrim, Henrik and Edgren, Gustaf},
title = {Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.14445}
}
EUVIMED